Amlodipine/Valsartan for Newly Diagnosed Hypertension
Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
Recruiting
Observational Study
Hypertension
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 70
Sex
Any
Study type
Observational
Participants needed
420 (estimated)
Sponsor
The Searle Company Limited Pakistan · Industry
Who this trial is looking for
This trial is looking for adults who have just been diagnosed with high blood pressure and have never been treated for it before. Participants will take a medication that combines two treatments to help lower their blood pressure and will provide feedback about their experience.
Are You a Good Fit for This Trial?
You may be able to join if
I have been diagnosed with high blood pressure.
I have never received treatment for my high blood pressure.
I am between 18 and 70 years old.
I can understand and sign a consent form.
You may not be able to join if
I am already on treatment for high blood pressure.
I am pregnant or a nursing mother.
I have an acute illness or a psychiatric diagnosis.
I am allergic to the medication used in this trial.
I have previously been treated with this medication.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The American College of Cardiology/American Heart Association hypertension guidelines recommend treatment initiation with dual antihypertensive therapy in adults with stage 2 hypertension (corresponding to grade 1 and 2 in the ESH classification) and an average BP \>20/10 mm Hg above target. Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertens…
The American College of Cardiology/American Heart Association hypertension guidelines recommend treatment initiation with dual antihypertensive therapy in adults with stage 2 hypertension (corresponding to grade 1 and 2 in the ESH classification) and an average BP \>20/10 mm Hg above target. Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertension (high blood pressure). In Pakistan multiple studies were conducted on Hypertension and use of Single Pill Combination in uncontrolled Hypertension. However, no study was conducted to assess the role of Single Pill Combination (SPC) like Amlodipine and Valsartan in newly diagnosed hypertension and to assess their quality of life by patients' satisfaction with their medication after managing the hypertension with the SPC.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Patient with a clinical history of Hypertension (systolic blood pressure greater than or equal to 140 mmHg or a diastolic blood pressure greater than or equal to 90 mmHg) and never had antihypertensive treatment.
* Patient aged ≥18 and ≤70 years inclusive of either sex.
* Pati…
Inclusion Criteria:
* Patient with a clinical history of Hypertension (systolic blood pressure greater than or equal to 140 mmHg or a diastolic blood pressure greater than or equal to 90 mmHg) and never had antihypertensive treatment.
* Patient aged ≥18 and ≤70 years inclusive of either sex.
* Patient with ability to understand and sign written informed consent form.
Exclusion Criteria:
* • Patients with already on antihypertensive treatment or secondary hypertension
* Pregnant women or nursing mothers
* Patients with acute illnesses or psychiatric diagnosis
* Known hypersensitivity to Extor product, the metabolites, or formulation excipients.
* Treated with Extor to evaluate safety as per approved prescribing information for Extor in Pakistan.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.